76
DuoGenic StemCells corporation
7607.TWO · TWO
$10.30 -1.44% (-$0.15)
1M -16.73%
Market Cap $383.0M
P/E Ratio -
Div. Yield -
ROE 82.42%
Piotroski F-Score Weak
3/9Valuation
3 /100
Expensive P/S 18.51x
P/B 7.51x
P/E N/A
Growth
78 /100
Growing Rev. growth 44.47%
Book val. growth 11.52%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 76.33%
FCF margin 90.52%
Net margin 127.48%
Quality
3 /100
Poor ROIC 35.17%
Asset turnover 0.26x
ROE 82.42%
Debt
64 /100
Moderate Debt/Equity 0.44x
Int. coverage -28.33x
Current ratio 2.24x
Stability
24 /100
Unstable Beta -0.17x
Profitable years 0
Rev. volatility 57.80%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 7607.TWO
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Chih Yao Lin
Employees
15
Headquarters
Taichung City